The Workplace-Based Hypertension Management Program

Condition(s) studied

Investigational drug(s) / intervention(s)

Workplace-based Multicomponent Hypertension Management Program: Multicomponent strategies, including default scheduling of BP monitoring and counseling sessions, personalized reminders via workplace digital systems, social comparison feedback using anonymized peer data, small incentives and commitment devices.

Routine workplace health education and management according to current guidelines.: Routine workplace health education and management according to current guidelines, including routine health education, standard hypertension counseling, and usual workplace health services.

Study summary

This study aims to evaluate the effectiveness of a workplace-based, multicomponent hypertension management program for newly diagnosed patients. Investigators will recruit 512 participants (256 pairs) from the Kailuan Study in Tangshan, China. Participants will be randomly assigned to receive a Workplace-based Multicomponent Hypertension Management Program or Standard Workplace Health Management. The primary objective is to assess improvements in blood pressure control and hypertension-related health behaviors.

Eligibility

Primary outcome measure(s)

• Change in systolic and diastolic blood pressure — up to 12 months
  Change in systolic and diastolic blood pressure from baseline to 12 months

Trial sites (1)

More Guangxi Medical University trials in China

Other trials for the same condition